These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32621739)

  • 1. Early Combination of Tocilizumab and Corticosteroids: An Upgrade in Anti-inflammatory Therapy for Severe Coronavirus Disease (COVID).
    Martínez-Urbistondo D; Costa Segovia R; Suárez Del Villar Carrero R; Risco Risco C; Villares Fernández P
    Clin Infect Dis; 2021 May; 72(9):1682-1683. PubMed ID: 32621739
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined therapy of tocilizumab and corticosteroids in severe SARS-CoV-2 disease.
    González-Castro A; Cuenca Fito E; Fernandez A; Escudero Acha P; Rodríguez Borregán JC; Peñasco Y
    Med Intensiva (Engl Ed); 2022 May; 46(5):285-287. PubMed ID: 35256321
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intestinal perforation in patient with COVID-19 infection treated with tocilizumab and corticosteroids. Report of a clinical case].
    Gonzálvez Guardiola P; Díez Ares JÁ; Peris Tomás N; Sebastián Tomás JC; Navarro Martínez S
    Cir Esp (Engl Ed); 2021 Feb; 99(2):156-157. PubMed ID: 32402416
    [No Abstract]   [Full Text] [Related]  

  • 4. Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab.
    Langer-Gould A; Smith JB; Gonzales EG; Castillo RD; Figueroa JG; Ramanathan A; Li BH; Gould MK
    Int J Infect Dis; 2020 Oct; 99():291-297. PubMed ID: 32768693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: comment.
    Yurttutan S; Gullu UU; Ipek S
    Intern Emerg Med; 2021 Jun; 16(4):1101-1103. PubMed ID: 33598871
    [No Abstract]   [Full Text] [Related]  

  • 6. Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: reply.
    Aomar-Millán IF; Salvatierra J; Hernández-Quero J
    Intern Emerg Med; 2021 Jun; 16(4):1105-1106. PubMed ID: 33694056
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination therapy of tocilizumab and steroid for COVID-19 patients: A meta-analysis.
    Moosazadeh M; Mousavi T
    J Med Virol; 2022 Apr; 94(4):1350-1356. PubMed ID: 34850411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tocilizumab and Systemic Corticosteroids in the Management of Patients with COVID-19: A Systematic Review and Meta-Analysis.
    Alkofide H; Almohaizeie A; Almuhaini S; Alotaibi B; Alkharfy KM
    Int J Infect Dis; 2021 Sep; 110():320-329. PubMed ID: 34273515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopharmacology of COVID-19.
    Bilbul M; Paparone P; Kim AM; Mutalik S; Ernst CL
    Psychosomatics; 2020; 61(5):411-427. PubMed ID: 32425246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuating COVID-19 infection and inflammation: Lessons from asthma.
    Bardin PG; Johnston SL
    Respirology; 2020 Dec; 25(12):1233-1234. PubMed ID: 33051923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerating the Evolution of Severe Acute Respiratory Syndrome Coronavirus 2: A Risk of Combining Dexamethasone and Tocilizumab for Severe Coronavirus Disease 2019.
    Koeckerling D; Barker J
    J Infect Dis; 2021 Sep; 224(6):934-937. PubMed ID: 34157110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pandemic and promise: progress towards finding an effective treatment for Novel Coronavirus 19.
    Merone L; Finlay S
    Aust N Z J Public Health; 2020 Dec; 44(6):437-439. PubMed ID: 33044799
    [No Abstract]   [Full Text] [Related]  

  • 13. IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19?
    Kow CS; Zaihan AF; Ramachandram DS; Hasan SS
    Cytokine; 2022 Jan; 149():155730. PubMed ID: 34628129
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply: Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk.
    Chen XJC; Altshuler D; Spiegler P; Brosnahan SB
    Ann Pharmacother; 2022 Apr; 56(4):507-508. PubMed ID: 34330173
    [No Abstract]   [Full Text] [Related]  

  • 15. Comment: Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk.
    Bissell BD; Mefford B; Donaldson JC
    Ann Pharmacother; 2022 Apr; 56(4):505-506. PubMed ID: 34330160
    [No Abstract]   [Full Text] [Related]  

  • 16. Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk.
    Brosnahan SB; Chen XJC; Chung J; Altshuler D; Islam S; Thomas SV; Winner MD; Greco AA; Divers J; Spiegler P; Sterman DH; Parnia S
    Ann Pharmacother; 2022 Mar; 56(3):237-244. PubMed ID: 34180274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Survival Analysis of Immunomodulatory Therapy for Coronavirus Disease 2019 Cytokine Storm.
    Narain S; Stefanov DG; Chau AS; Weber AG; Marder G; Kaplan B; Malhotra P; Bloom O; Liu A; Lesser ML; Hajizadeh N;
    Chest; 2021 Mar; 159(3):933-948. PubMed ID: 33075378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19, steroids and other immunomodulators: The jigsaw is not complete.
    Rello J; Waterer GW; Bourdiol A; Roquilly A
    Anaesth Crit Care Pain Med; 2020 Dec; 39(6):699-701. PubMed ID: 33115684
    [No Abstract]   [Full Text] [Related]  

  • 19. Audio Interview: Tocilizumab and Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Oct; 383(17):e114. PubMed ID: 33085870
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current and future therapeutic options for COVID-19].
    Dankers M; Nelissen-Vrancken HMJMG; Berger MY; Bonten MJM; van Gerven JMA; Kunst PWA; Muller M; Olde Rikkert MGM; Rosendaal FR
    Ned Tijdschr Geneeskd; 2022 Jul; 166():. PubMed ID: 36036702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.